| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.12B | -37.5% |
| Cost of Revenue | $693.7M | -8.4% |
| Gross Profit | $385.8M | -57.2% |
| R&D Expense | $193.0M | -17.5% |
| SG&A Expense | $340.3M | -2.3% |
| Operating Income | -$172.7M | -149.0% |
| Interest Expense | $37.3M | +8.1% |
| Pre-tax Income | -$221.7M | -170.5% |
| Income Tax | $2.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $642.6M | +11.5% |
| Accounts Receivable | $158.4M | -42.3% |
| Inventory | $351.8M | +0.3% |
| Current Assets | $1.21B | -4.8% |
| Total Assets | $3.17B | +7.0% |
| Current Liabilities | $1.23B | +229.0% |
| Long-term Debt | $1.41B | +66.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.1M | -110.6% |
| Capital Expenditures | $115.8M | -48.5% |
| Investing Cash Flow | -$381.3M | -69.5% |
| Financing Cash Flow | $481.2M | +441.3% |
| Free Cash Flow | -$149.9M | -256.0% |
| -97.5% |
| Net Income | -$223.8M | -196.9% |
| EPS (Basic) | -$4.47 | -203.5% |
| EPS (Diluted) | -$4.47 | -204.7% |
| Total Liabilities |
| $1.78B |
| +33.1% |
| Stockholders' Equity | $1.38B | -14.6% |